Pharma Industry News
A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Opinion | Gavin Newsom, Pharma Baron
Gov. Gavin Newsom said last week that California plans to launch its own “affordable” generic insulin to disrupt the pharmaceutical market. This is from the people who brought you $5-a-gallon gasoline. Mr. Newsom announced his desire…
Swiss pharma exports to Russia continue despite war
Companies justify this with their responsibility towards patients, but there is no shortage of criticism. According to figures from the Federal Customs and Border Security Service (FCAB), in 2024 the industry supplied the Russian Federation with…
Pills, profits and peril: How India's export-driven pharma machine puts Americans at severe risk * WorldNetDaily * by Amanda Bartolotta
It's every parent's nightmare: Racing their child to the emergency room, only to learn that the cough syrup they gave their son or daughter, rather than relieving their cough, instead had poisoned their child. It's the kind of horror story no one…
Looking Into Ascendis Pharma AS's Recent Short Interest - Ascendis Pharma (NASDAQ:ASND)
Ascendis Pharma AS's (NYSE:) short interest as a percent of float has risen 11.87% since its last report. According to exchange reported data, there are now 2.56 million shares sold short, which is 5.09% of all regular shares that are available for…
Bitter pill: Exposure of Indian pharma to US tariffs
Each new day is a new day for tariffs and last week the pharmaceutical sector was caught in the crossfire. The Trump administration's prospective imposition of tariffs on pharmaceutical imports is a notable departure from the long-standing…
CCI clears Torrent Pharma's proposal to buy stake in JB Chemicals
Fair trade regulator CCI on Tuesday cleared Torrent Pharmaceuticals Ltd's proposed acquisition of a stake in JB Chemicals and Pharmaceuticals, subject to voluntary modifications offered by the companies. The development came after Torrent…
Royalty Pharma PLC (NASDAQ:RPRX) Short Interest Update
Royalty Pharma PLC (NASDAQ:RPRX - Get Free Report) was the recipient of a large drop in short interest during the month of September. As of September 30th, there was short interest totaling 12,870,000 shares, a drop of 39.5% from the September 15th…
NewAmsterdam Pharma (NASDAQ:NAMS) Coverage Initiated by Analysts at HC Wainwright
Equities researchers at HC Wainwright started coverage on shares of NewAmsterdam Pharma (NASDAQ:NAMS - Get Free Report) in a research note issued to investors on Monday, Marketbeat reports. The brokerage set a 'buy' rating and a $52.00 price target…
Raymond James Financial Raises BridgeBio Pharma (NASDAQ:BBIO) Price Target to $59.00
BridgeBio Pharma (NASDAQ:BBIO - Get Free Report) had its target price hoisted by Raymond James Financial from $56.00 to $59.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has an…
Allianz Asset Management GmbH Increases Stock Position in Royalty Pharma PLC $RPRX
Allianz Asset Management GmbH grew its stake in shares of Royalty Pharma PLC (NASDAQ:RPRX - Free Report) by 87.3% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 362,546 shares of…
Big Pharma Is Paying Doctors to Prescribe Drugs for Multiple Sclerosis
An analysis showed that 78.5% of neurologists received payments from pharmaceutical companies, with doctors receiving more money prescribing more multiple sclerosis (MS) drugs from those companies Payment amounts create dose-dependent effects. Even…
Nxera's Partner Cancer Research UK Presents Data from Successfully Completed Phase 1 Clinical Trial of Cancer Immunotherapy Drug HTL0039732 at ESMO
HTL0039732 (also known as NXE0039732) is Nxera's novel oral EP4 antagonist with the potential to treat a wide range of cancers in combination with other immunotherapies HTL0039732, was found to be well-tolerated, confirmed target engagement and…
New weight loss drug hurdle as US states move to cut coverage
Novo Nordisk lobbied to win Medicaid reimbursement for its obesity drug Wegovy and it's now fighting to keep that coverage as some US states struggle with the treatment 's costs, according to state documents, company emails and interviews with…
Markets Glow on Muhurat Trading as Nifty, Sensex Open Samvat 2082 with Festive Gains
India's stock markets ushered in the new Samvat Year 2082 on a positive note during the special one-hour Muhurat trading session on Tuesday, as investors welcomed the festive season with optimism and steady buying interest. Both benchmark indices…
Novo Nordisk board members step down after clash with controlling shareholder
The Danish pharma giant said Tuesday that board directors and the Novo Nordisk Foundation — the firm's controlling shareholder — failed to reach an agreement on the future composition of the board. Mads Claus Rasmussen | Afp | Getty…
Receive a Daily briefing on Pharma Industry News
Get Started